COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia
KeywordsCOVID-19, SARS-CoV-2, CLL, chronic lymphocytic leukaemia, lymphocytosis, leucocytosis, lymphopenia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/?l) in CLL patients.
Issue: 2021: Vol 8 No 3 (view)